Legal Status Overview
Gray AreaPeptides are not legal for unrestricted human use in Georgia when sold as unapproved 'research chemicals'; Georgia has no peptide-specific statute, so the state simply layers its pharmacy licensing and compounding rules on top of the federal Food, Drug and Cosmetic Act. The Georgia Board of Pharmacy regulates compounding pharmacies (503A) and outsourcing facilities (503B) under Georgia's Pharmacy Practice Act, and the Georgia Composite Medical Board governs the physician prescribing and telehealth/good-faith-exam rules that make peptide use lawful. Compounds like BPC-157 and TB-500 remain unapproved new drugs under federal law regardless of Georgia licensing, while GLP-1 peptides (semaglutide, tirzepatide) are FDA-approved but their compounded versions are only legally compoundable in narrow, patient-specific circumstances now that federal shortage designations have ended.
Key Points
- Georgia has no statute, administrative rule, or Board of Pharmacy regulation that names 'peptides' or 'research chemicals' as a distinct legal category; the Georgia Pharmacy Practice Act (O.C.G.A. Title 26, Ch. 4) only defines general terms like 'compounding' without singling out peptides. [2]
- The Georgia Board of Pharmacy treats a pharmacy that compounds patient-specific prescriptions as an FDA 503A facility, requiring only the pharmacy's existing Georgia license and adherence to Georgia's compounding rules, not a separate FDA registration. [3]
- A 2016 amendment to Georgia's Pharmacy Practice Act restricts non-patient-specific 'office use' compounding to licensed FDA 503B outsourcing facilities, with exceptions for hospital-based pharmacies and physicians compounding for their own patients. [4]
- Buying or bringing unapproved research-peptide products like BPC-157 or TB-500 into Georgia for personal human use is not protected by any Georgia-specific allowance; these compounds remain federally unapproved new drugs, so possession or use for oneself carries legal risk even though Georgia does not add a state-specific criminal peptide statute on top of federal law. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- Georgia prescribers can lawfully offer FDA-approved GLP-1 peptides (semaglutide, tirzepatide) through MDs, DOs, NPs with a protocol agreement, or PAs under physician supervision, making licensed prescription the legal pathway to obtain these peptides in Georgia. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- Since the FDA declared the tirzepatide shortage resolved in October 2024 and the semaglutide shortage resolved on February 21, 2025, Georgia compounding pharmacies operating under 503A/503B rules can no longer routinely compound copies of these GLP-1 drugs except for documented, patient-specific clinical needs. [5]
- Georgia Composite Medical Board rules require prescribers offering compounded or telehealth-prescribed peptides such as GLP-1s to document a good-faith examination under GCMB Rule 360-32-.06 and O.C.G.A. §43-34-31.1 and to source medications only from Georgia Board of Pharmacy-registered facilities inspected by the Georgia Drugs and Narcotics Agency. [6]
- Federal law makes it a crime to distribute human growth hormone (HGH/somatropin) for any purpose other than treating a disease or a recognized medical condition authorized by HHS and pursuant to a physician's order, and Georgia has adopted no separate state HGH statute that alters this framework. [11]
Peptide-by-peptide status in Georgia
| BPC-157 | BPC-157 is not FDA-approved and remains an unapproved research chemical in Georgia, meaning it cannot lawfully be prescribed, compounded for retail sale, or sold over the counter for human use, regardless of Georgia's lack of a peptide-specific statute. [7] |
|---|---|
| TB-500 | TB-500 has the same unapproved status as BPC-157 in Georgia, since FDA's compounding advisory committee has only recommended reconsidering restrictions on it and this recommendation does not make it an FDA-approved or lawfully compoundable drug. [9] |
| Semaglutide / Tirzepatide (GLP-1 class) | Semaglutide and tirzepatide are FDA-approved prescription drugs that can be lawfully prescribed in Georgia by MDs, DOs, NPs with a protocol agreement, or supervised PAs, but Georgia compounding pharmacies can no longer routinely sell compounded 'copies' of these drugs now that the federal drug-shortage exemptions ended in late 2024/early 2025. |
| Human Growth Hormone (HGH/somatropin) | HGH is a prescription-only drug in Georgia, and under federal law distributing it for any purpose other than treating a disease or HHS-recognized medical condition and outside a physician's order is a criminal offense, a rule Georgia has not modified with any state-specific carve-out. [11] |
Sources
Last researched: 2026-09-09
Frequently asked questions
Can I buy peptides in Georgia without a prescription?
No -- in Georgia, unapproved research peptides like BPC-157 and TB-500 cannot be lawfully sold for human use without a prescription, since they are unapproved new drugs under federal law that Georgia's pharmacy licensing system enforces rather than overrides. Only FDA-approved peptide drugs (like semaglutide or tirzepatide) can be legally dispensed, and only pursuant to a valid prescription from a licensed Georgia prescriber. [7]
Is it legal to get compounded semaglutide or tirzepatide through telehealth in Georgia?
Compounded GLP-1 telehealth prescribing is legal in Georgia only in narrow, patient-specific circumstances now that FDA ended the shortage exemptions in late 2024/early 2025, and Georgia prescribers must still perform a documented good-faith exam under GCMB Rule 360-32-.06 and O.C.G.A. §43-34-31.1. Mass-market compounded GLP-1 telehealth offers that don't meet the patient-specific standard are legally questionable and subject to FDA and state enforcement. [6]
What happens if I get caught with research-grade peptides in Georgia?
Georgia has no specific criminal peptide statute, so enforcement generally proceeds through federal channels (FDA unapproved-new-drug violations) or through state consumer-protection and pharmacy-board actions against sellers, as seen in other states where attorneys general have sued distributors of 'research-grade' peptides marketed to consumers. Georgia's Board of Pharmacy and Georgia Drugs and Narcotics Agency can also take licensing action against pharmacies or prescribers involved in improper peptide distribution. [12]
Is BPC-157 legal in Georgia?
BPC-157 is not legal for general human use in Georgia because it is an unapproved drug under federal law with no FDA-recognized therapeutic indication, and Georgia has adopted no state exception that would make it lawful to sell or prescribe outside a formal drug-approval or authorized-research pathway. [7]
How can someone legally obtain peptides like semaglutide in Georgia?
The legal pathway in Georgia is a prescription from a licensed prescriber -- an MD, DO, NP with a protocol agreement, or a PA under physician supervision -- filled at a pharmacy properly licensed by the Georgia Board of Pharmacy, using either the FDA-approved brand product or, in limited documented cases, a 503A/503B-compliant compounded version.